| Nanoplatforms for cancer theranostics | Lifetime | 26 | CN 19 | 99.86 |
| Nanoparticle-Based Drug Delivery | Lifetime | 34 | CN 11 | 99.77 |
| Extracellular vesicles in disease | Lifetime | 36 | CN 9 | 99.44 |
| RNA Interference and Gene Delivery | Lifetime | 187 | CN 29 | 99.37 |
| Advanced biosensing and bioanalysis techniques | Lifetime | 412 | CN 185 | 99.07 |
| Photoacoustic and Ultrasonic Imaging | Lifetime | 217 | CN 35 | 98.18 |
| Advanced Nanomaterials in Catalysis | Lifetime | 296 | CN 208 | 98.65 |
| Graphene and Nanomaterials Applications | Lifetime | 250 | CN 104 | 98.44 |
| Photodynamic Therapy Research Studies | Lifetime | 272 | CN 46 | 96.97 |
| Iron oxide chemistry and applications | Lifetime | 638 | CN 113 | 94.75 |
| Carbon and Quantum Dots Applications | Lifetime | 739 | CN 513 | 93.29 |
| Protein Tyrosine Phosphatases | Lifetime | 851 | CN 77 | 86.69 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 40 | CN 35 | 99.68 |
| Extracellular vesicles in disease | 2021-2025 | 51 | CN 35 | 98.61 |
| RNA Interference and Gene Delivery | 2021-2025 | 61 | CN 34 | 98.60 |
| Photodynamic Therapy Research Studies | 2021-2025 | 40 | CN 26 | 97.41 |
| Immunotherapy and Immune Responses | 2021-2025 | 335 | CN 97 | 95.62 |
| Advanced biosensing and bioanalysis techniques | 2021-2025 | 521 | CN 381 | 97.05 |
| Hepatocellular Carcinoma Treatment and Prognosis | 2021-2025 | 246 | CN 51 | 97.16 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 212 | CN 82 | 96.12 |
| Advanced Nanomaterials in Catalysis | 2021-2025 | 386 | CN 277 | 96.28 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 349 | CN 148 | 92.49 |
| Photoacoustic and Ultrasonic Imaging | 2021-2025 | 336 | CN 142 | 91.86 |
| Virus-based gene therapy research | 2021-2025 | 530 | CN 143 | 89.69 |
| Cancer Research and Treatments | 2021-2025 | 512 | CN 221 | 84.41 |
| MRI in cancer diagnosis | 2021-2025 | 700 | CN 183 | 86.08 |
| Viral Infectious Diseases and Gene Expression in Insects | 2021-2025 | 406 | CN 56 | 83.84 |
| Breast Lesions and Carcinomas | 2021-2025 | 406 | CN 27 | 84.46 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 886 | CN 73 | 86.10 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 246 | CN 100 | 80.49 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 487 | CN 67 | 83.62 |
| Carbon and Quantum Dots Applications | 2021-2025 | 977 | CN 596 | 83.85 |
| Phagocytosis and Immune Regulation | 2021-2025 | 352 | CN 143 | 78.04 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 857 | CN 228 | 72.47 |
| Parasitic infections in humans and animals | 2021-2025 | 315 | CN 70 | 76.16 |
| Microfluidic and Capillary Electrophoresis Applications | 2021-2025 | 922 | CN 308 | 74.93 |
